Literature DB >> 26807015

Vascular Perfusion of Implanted Human Engineered Cardiac Tissue.

Kareen L K Coulombe1, Charles E Murry2.   

Abstract

Regeneration of muscle tissue in the heart after a myocardial infarction requires delivering human cardiomyocytes that will survive and integrate with the host myocardium. Of primary importance is the development of a vascular bed to nourish the implanted cardiomyocytes, whether delivered via injection or in engineered tissues. Co-culture of hESC-derived cardiomyocytes, human endothelial cells, and human stromal cells provides a prevascular network in scaffold-free engineered tissue patches. As a result, the density of lumen structures in the graft increases by histological analysis, but perfusion of these vessels must be assessed. In this study, we develop a method for perfusing the host heart and engineered human cardiac tissue graft that is compatible with confocal microscopy for obtaining 2D images and 3D reconstructions of the graft vasculature. We demonstrate that, although vascular density is substantial in the grafts, flow remains sluggish. Further improvements in arterial remodeling or vascular engineering are required for physiological levels of blood flow.

Entities:  

Keywords:  cardiac tissue engineering; myocardial infarction; stem cell biology; vascular perfusion

Year:  2014        PMID: 26807015      PMCID: PMC4721559          DOI: 10.1109/NEBEC.2014.6972763

Source DB:  PubMed          Journal:  Proc IEEE Annu Northeast Bioeng Conf        ISSN: 1071-121X


  5 in total

1.  Three-dimensional reconstruction of the human capillary network and the intramyocardial micronecrosis.

Authors:  Noboru Kaneko; Ryuko Matsuda; Masashi Toda; Ken Shimamoto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

2.  Developing vasculature and stroma in engineered human myocardium.

Authors:  Kareen L Kreutziger; Veronica Muskheli; Pamela Johnson; Kathleen Braun; Thomas N Wight; Charles E Murry
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

3.  Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis.

Authors:  Mami Murakami; Mark J Ernsting; Elijus Undzys; Nathan Holwell; Warren D Foltz; Shyh-Dar Li
Journal:  Cancer Res       Date:  2013-08-01       Impact factor: 12.701

4.  Transplantation of a tissue-engineered human vascularized cardiac muscle.

Authors:  Ayelet Lesman; Manhal Habib; Oren Caspi; Amira Gepstein; Gil Arbel; Shulamit Levenberg; Lior Gepstein
Journal:  Tissue Eng Part A       Date:  2010-01       Impact factor: 3.845

5.  Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats.

Authors:  Kyu-Tae Kang; Matthew Coggins; Chunyang Xiao; Anthony Rosenzweig; Joyce Bischoff
Journal:  Angiogenesis       Date:  2013-05-12       Impact factor: 9.596

  5 in total
  2 in total

1.  Stromal Cells in Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue.

Authors:  Meredith A Roberts; Dominic Tran; Kareen L K Coulombe; Maria Razumova; Michael Regnier; Charles E Murry; Ying Zheng
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

2.  Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts.

Authors:  Meredith A Redd; Nicole Zeinstra; Wan Qin; Wei Wei; Amy Martinson; Yuliang Wang; Ruikang K Wang; Charles E Murry; Ying Zheng
Journal:  Nat Commun       Date:  2019-02-04       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.